Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-04-30Clinical Trial Update: The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia [Phase 3]
A Phase 3 clinical trial evaluating green tea extract for people with type 2 diabetes and hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis [Phase 2]
Phase 2 trial update for TZP-102 evaluating treatment of symptoms in diabetic gastroparesis. Study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes [Phase 2]
Pfizer completed a Phase 2 trial evaluating the safety and efficacy of PF-04991532 in adults with type 2 diabetes; results were posted in 20…
-
CLINICAL_TRIALS research · 2013-04-23Clinical Trial Update: Prevalence of HbA1C in Women With PCOS
This clinical trial update describes a study on the prevalence of HbA1c levels among women with polycystic ovary syndrome, with related cond…
-
FDA approval · 2013-04-22FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 study evaluating the effect of Canagliflozin (JNJ-28431754) on post-meal glucose in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus [Phase 1]
This clinical trial update describes a Phase 1 study comparing two methods for determining the renal threshold for glucose in adults with Ty…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects [Phase 1]
A Phase 1 trial evaluating AMG 151 on 24-hour ambulatory blood pressure and glucose levels in Type 2 diabetes subjects has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly
A completed clinical study from University of Campinas investigates aging endocrine pancreas and entero-insular axis physiology in elderly, …
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth [NA]
A completed pediatric trial examining the effects of rosiglitazone on the metabolic phenotype of impaired glucose tolerance in youth, with r…
-
CLINICAL_TRIALS research · 2013-04-19Clinical Trial Update: Internet Diabetes Self-Management Workshop [NA]
This document provides an update on a completed clinical trial evaluating an Internet-based diabetes self-management workshop for people wit…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Tactile Massage in Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial evaluating tactile massage for Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) [Phase 3]
The AVALANCHE Phase 3 trial compares rosiglitazone-based regimens (Avandia + Amaryl or Avandamet) with metformin in Type 2 diabetes and has …
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients [Phase 4]
Clinical trial update describing a Phase 4 study evaluating nitazoxanide, interferon alfa, and ribavirin for hepatitis C in patients with ty…
-
FDA approval · 2013-04-17FDA Approved: GLIMEPIRIDE — Original Application (Florida Pharmaceutical Products, LLC)
The FDA approved an Original Application for a generic version of glimepiride by Florida Pharmaceutical Products, LLC. The approval enables …
-
FDA label_change · 2013-04-16FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for liraglutide from Teva Pharmaceuticals USA, Inc., resulting in changes to the product labelin…
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Cost Effectiveness of Glargine Insulin Versus NPH Insulin [Phase 4]
This Phase 4 study assesses the cost-effectiveness of branded insulin glargine compared with NPH insulin in Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Protein Profile of Immunoregulatory Factors in Diabetic Cataract [Phase 4]
This entry reports the completion of a Phase 4 clinical trial investigating the protein profile of immunoregulatory factors in diabetic cata…
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Double Blind Comparative Study of TAK-875 [Phase 3]
A Phase 3 double-blind comparative study of TAK-875 in diabetic patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Adiponectin and Ethnic Differences in Insulin Resistance
This completed clinical trial examines the relationship between adiponectin levels and insulin resistance across different ethnic groups, wi…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition [Phase 1]
A Phase 1 bioequivalence study of Metformin hydrochloride extended-release tablets USP 750 mg under fed condition has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function [Phase 1]
Phase 1 pharmacokinetic and safety/tolerability study of a single subcutaneous PB1023 dose conducted in subjects with normal and impaired re…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Physical Activity in Overweight Girls: Implications for Reversing Risk Factors for Type 2 Diabetes [NA]
A completed University of Pittsburgh clinical trial evaluated physical activity in overweight girls and its implications for reversing risk …
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan [Phase 4]
Phase 4 clinical trial update examining how to manage insulin-treated type 2 diabetes patients during Ramadan.
-
FDA approval · 2013-04-10FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.